Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial
Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually relieve the severity of symptoms by as much as 20 –30%, and satisfactory treatment is obtained in 40–60% of pat...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Ala Ghobadian, Saba Mokhtari, Behnam Shariati, Leila Kamalzadeh, Mohsen Shati, Mehrdad Eftekhar Ardebili, Masoomeh Yarahmadi and Mohammadreza Shalbafan Tags: Research Source Type: research
More News: Clinical Trials | Drugs & Pharmacology | Obsessive Compulsive Disorder | Sertraline | Zoloft